Heath Lukatch

Insider Reports History

Entity: Individual
Location: 326 Bollay Drive, Goleta, CA
Signature: Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Vaxcyte, Inc.	Director	Common Stock	7.18K	$524K	$73.00	Jun 6, 2024	Direct
Inogen Inc	Director	Common Stock	12.8K	$73.1K	$5.72	May 10, 2021	Direct
Vaxcyte, Inc.	Director	Stock Option (right to buy)	7.25K			Jun 6, 2024	Direct
Flexion Therapeutics Inc	Director	Common Stock	0		$8.50	Nov 19, 2021	Direct
Flexion Therapeutics Inc	Director	Stock option (right to buy)	0			Nov 19, 2021	Direct
Satsuma Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	0			Jun 8, 2023	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PCVX	Vaxcyte, Inc.	Jun 6, 2024	2	$0	4	Jun 10, 2024	Director
PCVX	Vaxcyte, Inc.	Jan 31, 2024	3	-$278K	4	Feb 2, 2024	Director
PCVX	Vaxcyte, Inc.	Jan 29, 2024	3	-$206K	4	Jan 31, 2024	Director
PCVX	Vaxcyte, Inc.	Jan 2, 2024	6	-$621K	4	Jan 4, 2024	Director
PCVX	Vaxcyte, Inc.	Jun 13, 2023	2	$0	4	Jun 15, 2023	Director
STSA	Satsuma Pharmaceuticals, Inc.	Jun 8, 2023	3	$0	4	Jun 8, 2023	Director
PCVX	Vaxcyte, Inc.	Jan 10, 2023	4	-$9.49K	4	Jan 12, 2023	Director
PCVX	Vaxcyte, Inc.	Dec 12, 2022	4	-$9.36K	4	Dec 14, 2022	Director
PCVX	Vaxcyte, Inc.	Nov 10, 2022	4	-$131K	4	Nov 15, 2022	Director
PCVX	Vaxcyte, Inc.	Oct 24, 2022	6	-$147K	4	Oct 26, 2022	Director
STSA	Satsuma Pharmaceuticals, Inc.	Jun 3, 2022	1	$0	4	Jun 7, 2022	Director
PCVX	Vaxcyte, Inc.	Jun 1, 2022	2	$0	4	Jun 3, 2022	Director
FLXN	Flexion Therapeutics Inc	Nov 19, 2021	6	-$76.5K	4	Nov 19, 2021	Director
FLXN	Flexion Therapeutics Inc	Jun 24, 2021	2	$0	4	Jun 28, 2021	Director
PCVX	Vaxcyte, Inc.	Jun 2, 2021	1	$0	4	Jun 3, 2021	Director
INGN	Inogen Inc	May 10, 2021	1	$0	4	May 12, 2021	Director